SCHEMBL29583687

SCHEMBL29583687

CN1C(=O)c2ccccc2Nc2ncncc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 1/20 0.40
▸ TTR P02766 1/20 0.39
▸ CES1 P23141 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ CYP1A2 P05177 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ GFER P55789 1/20 0.37
▸ AKT1 P31749 2/20 0.36
▸ GSK3B P49841 2/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ CLK4 Q9HAZ1 2/20 0.35
▸ DAPK3 O43293 1/20 0.35
▸ PRKD3 O94806 1/20 0.35
▸ MAP4K4 O95819 1/20 0.35
▸ PAK4 O96013 1/20 0.35
▸ ABL1 P00519 1/20 0.35
▸ LCK P06239 1/20 0.35
▸ CSF1R P07333 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11279342 0.83 ALDH1A1 (0.44) CASP3TTRCES1ALDH1A1CYP1A2
SCHEMBL11486350 0.79 ALDH1A1 (0.55) ALDH1A1CYP1A2SMN1; SMN2AKT1
SCHEMBL24334888 0.78 CASP3 (0.38) CASP3TTRCES1ALDH1A1CYP1A2
SCHEMBL29531391 0.74 MAPK7 (0.49) CASP3TTRCES1TNK2TRPA1
SCHEMBL19496540 0.74 MAPK7 (0.49) CASP3TTRCES1TNK2TRPA1
SCHEMBL7982510 0.73 TTR (0.55) CASP3TTRCES1ALDH1A1SMN1; SMN2
SCHEMBL20875235 0.73 PDGFRA (0.55) ALDH1A1CYP1A2SMN1; SMN2GSK3BALOX15
Hydrochloric Acid SCHEMBL29530065 0.72 MAPK7 (0.48) CASP3TTRCES1TNK2TRPA1
SCHEMBL16980134 0.71 POLB (0.39) CASP3TTRCES1ALDH1A1CYP1A2
SCHEMBL5937266 0.71 ALDH1A1 (0.66) TTRCES1ALDH1A1CYP1A2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229061-A1 METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION Ranok Therapeutics (Hangzhou) Co. Ltd. (CN) 2023-08-23 — — EP disclosed
WO-2022078350-A1 METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION RANOK THERAPEUTICS (HANGZHOU) CO. LTD. (CN) 2022-04-21 — — WO disclosed
Send feedback